Tina Verschuere
Brussels, BRU, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Prognostic Significance of DNA Methylation Profiles at MRI Enhancing Tumor Recurrence: a Report from the EORTC 26091 TAVAREC Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 17, 2021
Myeloid-derived suppressor cells at diagnosis may discriminate between benign and malignant ovarian tumors.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: May 17, 2019
Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial.
Journal: The Lancet. Oncology
Published: March 15, 2018
Dynamic stroma reorganization drives blood vessel dysmorphia during glioma growth.
Journal: EMBO molecular medicine
Published: October 18, 2017
Characterization of PD-1 upregulation on tumor-infiltrating lymphocytes in human and murine gliomas and preclinical therapeutic blockade.
Journal: International journal of cancer
Published: January 07, 2017
Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma.
Journal: Science translational medicine
Published: March 04, 2016
The dark side of ID8-Luc2: pitfalls for luciferase tagged murine models for ovarian cancer.
Journal: Journal for immunotherapy of cancer
Published: July 16, 2015
Immunosuppressive parameters in serum of ovarian cancer patients change during the disease course.
Journal: Oncoimmunology
Published: July 06, 2015
Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma.
Journal: Oncoimmunology
Published: March 16, 2015
Wilms' Tumor Gene 1 (WT1)--loaded dendritic cell immunotherapy in patients with uterine tumors: a phase I/II clinical trial.
Journal: Anticancer research
Published: December 11, 2013
Immunological response after WT1 mRNA-loaded dendritic cell immunotherapy in ovarian carcinoma and carcinosarcoma.
Journal: Anticancer research
Published: September 12, 2013
Altered galectin-1 serum levels in patients diagnosed with high-grade glioma.
Journal: Journal of neuro-oncology
Published: April 15, 2013
Last Updated: 09/26/2026